Thought Leadership
 
Email Page
Little Impact Post-Arthrex for Biologic Patents at the PTAB
December 3, 2019
Stacie Ropka, Drew Hillier, and Gabriella Mahan*
The Center for Biosimilars

Axinn partner Stacie Ropka and associates Drew Hillier and Gabriella Mahan* authored The Center for Biosimilars article, "Little Impact Post-Arthrex for Biologic Patents at the PTAB."

Click here to access the article.

*Not yet admitted to the Washington, DC Bar